Suneva Medical (RNEW) CEO On Regenerative Aesthetics Products
b'Suneva Medical develops and manufactures regenerative aesthetics products. It also recently announced a SPAC merger agreement with Viveon Health Acquisition Corp. which is expected to be completed in the first half of 2022. Pat Altavilla, CEO of Suneva Medical, joins Nicole Petallides, to discuss the merger and how Suneva Medical will trade on the NYSE under the ticker \\u201cRNEW.\\u201d She also talks about the growth outlook for the regenerative aesthetics market. Tune in to find out more.'